Stock Market Today

Stock Market Today: Chip Rip Triggers Record Highs in Nasdaq, S&P

Elsewhere, Facebook closed above the $1 trillion market-cap level for the first time ever.

The technology sector's semiconductor industry took the reins on Monday and steered both the Nasdaq Composite and S&P 500 Index to fresh all-time highs to kick off the week.

Tech's gains (+1.1%) seemed to come at the expense of overheated cyclical plays, such as energy (-3.4%) and financials (-0.7%), and amid a decline in Treasury rates, with the 10-year yield off 6 basis points to 1.47% (a basis point is one one-hundredth of a percentage point).

"The move in rates is partially in response to some concerns related to the spread of the delta (COVID) variant, which has caused some countries to re-implement restrictions," says Michael Reinking, senior market strategist at the New York Stock Exchange. "This is also hitting oil prices, which briefly traded to a new high earlier before reversing lower." U.S. crude oil futures finished the day off 1.5% to $72.91 per barrel.

Helping lead tech's rally was Nvidia (NVDA, +5.0%), which jumped after fellow semiconductor firm Broadcom (AVGO, +2.3%) backed Nvidia's $40 billion buyout of chip designer Arm. Related names such as Intel (INTC, +2.8%) and Applied Materials (AMAT, +3.5%) followed suit.

Sign up for Kiplinger's FREE Investing Weekly e-letter for stock, ETF and mutual fund recommendations, and other investing advice.

The Nasdaq advanced by 1.0% to a record close of 14,500. The S&P 500's 0.2% gain wasn't as robust, but was enough for a new high of 4,290. The Dow Jones Industrial Average retreated, however, declining 0.4% to 34,283. 

Other action in the stock market today:

  • The small-cap Russell 2000 slipped 0.5% to 2,322.
  • Intellia Therapeutics (NTLA) surged 50.2% after the biotech over the weekend reported positive Phase I data for its gene-editing treatment for transthyretin amyloidosis, a genetic liver disorder in which the body builds up abnormal amounts of protein. The treatment, which is being developed with Regeneron Pharmaceuticals (REGN, -1.4%), is the "first-ever clinical data supporting safety and efficacy of in vivo CRISPR genome editing in humans," according to an NTLA press release.
  • Facebook (FB) jumped 4.2% after a federal judge in the District of Columbia dismissed an antitrust lawsuit brought forth by the Federal Trade Commission (FTC). "The FTC has failed to plead enough facts to plausibly establish a necessary element of all of its Section 2 claims – namely, that Facebook has monopoly power in the market for Personal Social Networking (PSN) Services," read the filing. Today's pop was enough for FB to close above the $1 trillion market-cap level for the first time ever. 
  • Gold futures edged up 0.2% to settle at $1,780.70 an ounce.
  • The CBOE Volatility Index (VIX) rose 0.9% to settle at 15.76.
  • Bitcoin prices jumped 6.9% to $34,455.73. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)
stock price chart 062821

YCharts

Maybe You Don't Need to Choose Between Growth and Value

Should investors bank in a continued resurgence of tech and other growthy names for the rest of 2021, or does value still have gas in the tank?

As we discussed today in our free A Step Ahead e-letter, Capital Group, the name behind American Funds, says you don't necessarily need to choose.

"There can be growing companies that are cheap and cheap companies that grow, so value and growth are not in opposition," says Capital Group equity portfolio manager Martin Romo. "We are in a target-rich environment with opportunities to invest in companies that are rapidly growing as well as classic cyclicals."

The "growing companies that are cheap and cheap companies that grow" he speaks of are better known by just four letters: GARP. That stands for "growth at a reasonable price," and even with the major indexes at or near all-time highs, several companies offer just that: the prospects for breakneck growth, but also valuations that represent discounts to their own historical multiples and/or the stock market's current valuation.

If you want your own portfolio to pack this one-two punch, check out these 11 GARP picks.

Kyle Woodley was long NVDA as of this writing. 

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
The 12 Best Consumer Discretionary Stocks to Buy for 2022
stocks to buy

The 12 Best Consumer Discretionary Stocks to Buy for 2022

Consumer discretionary stocks may be among 2022's most challenging places to invest in. But these picks could overcome several sector headwinds.
January 4, 2022
How to Know When You Can Retire
retirement

How to Know When You Can Retire

You’ve scrimped and saved, but are you really ready to retire? Here are some helpful calculations that could help you decide whether you can actually …
January 5, 2022

Recommended

Stock Market Today (1/24/22): Dow Erases 1,100-Point Intraday Drop to End Higher
Stock Market Today

Stock Market Today (1/24/22): Dow Erases 1,100-Point Intraday Drop to End Higher

The S&P 500 was on pace to close in correction territory before reversing higher.
January 24, 2022
Tesla Stock: TSLA Headlines Busiest Week of Earnings So Far
stocks

Tesla Stock: TSLA Headlines Busiest Week of Earnings So Far

Our preview of the upcoming week's earnings reports includes Tesla (TSLA), Apple (AAPL), Microsoft (MSFT), Intel (INTC) and Chevron (CVX).
January 24, 2022
8 Facts You Need to Know About Stock Market Corrections
Markets

8 Facts You Need to Know About Stock Market Corrections

Scary as they are, drawdowns are a normal part of the investing process. Having a financial plan in place and sticking to it is every investor's best …
January 23, 2022
Stock Market Today (1/21/22): Nasdaq Sinks Again, Ends Worst Week Since 2020
Stock Market Today

Stock Market Today (1/21/22): Nasdaq Sinks Again, Ends Worst Week Since 2020

A negative earnings reaction for Netflix (NFLX) and options expiration sparked a volatile session for stocks.
January 21, 2022